KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Current Assets (2016 - 2025)

Historic Current Assets for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $1.5 billion.

  • Idexx Laboratories' Current Assets rose 302.08% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 302.08%. This contributed to the annual value of $1.4 billion for FY2024, which is 637.73% down from last year.
  • Per Idexx Laboratories' latest filing, its Current Assets stood at $1.5 billion for Q3 2025, which was up 302.08% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Current Assets ranged from a high of $1.5 billion in Q2 2024 and a low of $938.0 million during Q3 2021
  • For the 5-year period, Idexx Laboratories' Current Assets averaged around $1.2 billion, with its median value being $1.2 billion (2023).
  • In the last 5 years, Idexx Laboratories' Current Assets skyrocketed by 5218.64% in 2021 and then crashed by 1227.45% in 2025.
  • Over the past 5 years, Idexx Laboratories' Current Assets (Quarter) stood at $955.7 million in 2021, then grew by 15.26% to $1.1 billion in 2022, then surged by 35.75% to $1.5 billion in 2023, then fell by 6.38% to $1.4 billion in 2024, then rose by 5.51% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.4 billion for Q2 2025, and $1.3 billion during Q1 2025.